Operating CF
$7.33B
Capex
−$1.90B
Free Cash Flow
$5.43B
FCF Margin
+74.0%
Cash flow waterfall for Medtronic (MDT) — TTM through Q2 2026
Free cash flow: $5.43B
Cash flow breakdown for Medtronic (MDT) — TTM through Q2 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $7.33B | $7.33B |
| Capital Expenditure | −$1.90B | $5.43B |
| Free Cash Flow | $5.43B | $5.43B |
| Acquisitions | −$406.00M | $5.02B |
| Other Investing | −$624.00M | $4.40B |
| Share Buybacks | −$1.03B | $3.36B |
| Dividends Paid | −$3.64B | −$278.00M |
| Net Debt Change | −$1.17B | −$1.45B |
| Other Financing | $1.10B | −$355.00M |
| Forex Effect | −$2.47B | −$2.82B |
| Net Cash Decrease | −$2.82B | −$2.82B |
- Operating Cash Flow$7.33B
- Capital Expenditure−$1.90B
- Free Cash Flow$5.43B
- Acquisitions−$406.00M
- Other Investing−$624.00M
- Share Buybacks−$1.03B
- Dividends Paid−$3.64B
- Net Debt Change−$1.17B
- Other Financing$1.10B
- Forex Effect−$2.47B
- Net Cash Decrease−$2.82B
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Medtronic (MDT) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement